CINGCingulate Inc.

Nasdaq cingulate.com


$ 13.31 $ 0.75 (5.97 %)    

Wednesday, 21-Aug-2024 11:13:30 EDT
QQQ $ 482.09 $ 0.97 (0.2 %)
DIA $ 408.71 $ -0.52 (-0.13 %)
SPY $ 560.12 $ 0.19 (0.03 %)
TLT $ 98.76 $ 0.08 (0.09 %)
GLD $ 231.53 $ -0.13 (-0.06 %)
$ 13.34
$ 12.56
$ 12.51 x 100
$ 13.36 x 100
$ 12.38 - $ 14.05
$ 1.80 - $ 187.20
9,972,310
na
7.82M
$ 0.17
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 04-01-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-10-2023 03-31-2023 10-Q
7 03-10-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-28-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 on-august-19-2024-cingulate-increased-the-maximum-offering-price-for-common-stock-under-its-sales-agreement-from-847m-to-11326658-and-filed-a-prospectus-supplement-for-an-additional-2856658-of-shares-having-already-sold-shares-worth-846840299-previously

- SEC Filing

 cingulate-shares-are-trading-by-more-than-200-friday-what-you-need-to-know

Cingulate Inc. (NASDAQ: CING) shares are on an upward trajectory Friday. It follows the announcement that Cingulate has been gr...

 cingulate-shares-resume-trade
Cingulate Shares Resume Trade
08/16/2024 18:58:35

 top-5-trending-stocks-of-the-day-amazon-ast-spacemobile-cingulate-applied-materials-and-tesla

On Thursday, major U.S. indices closed higher, with the Dow Jones Industrial Average increasing by 1.4% to 40,563.06.

 whats-going-on-with-cingulate-shares-today

Cingulate shares are surging, trading over 173% higher today. Here's what's driving the movement.

 cingulate-shares-resume-trade
Cingulate Shares Resume Trade
08/15/2024 17:45:06

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION